{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:42:59Z","timestamp":1770223379178,"version":"3.49.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":1616,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fibroblast growth factor (FGF)-23 is increased first in the sequence of changes associated with chronic kidney disease (CKD)-mineral and bone disorder. Thus, its measurement may serve as a predictive indicator of incident hyperphosphatemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate whether serum FGF-23 concentration in normophosphatemic dogs with CKD is associated with the risk of the subsequent development of hyperphosphatemia and CKD progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Forty-two normophosphatemic dogs with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood samples and medical records were retrospectively investigated. Hyperphosphatemia was defined as a serum phosphorous concentration &amp;gt;5.0\u00a0mg\/dL. Progression was defined as a &amp;gt;1.5-fold increase in serum creatinine concentration. The time periods and hazard ratios for these outcomes were assessed using Kaplan-Meier analysis, log-rank test, and univariate Cox regression analysis. The variables associated with the outcomes in the univariate analysis were included in the multivariate Cox regression model with backward selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum FGF-23 concentration &amp;gt;528\u2009pg\/mL was associated with a shorter time to development of hyperphosphatemia (P\u2009&amp;lt;\u2009.001) and CKD progression (P\u2009&amp;lt;\u2009.001). In multiple Cox regression analysis, increased FGF-23 concentration remained a significant variable associated with these outcomes (P\u2009&amp;lt;\u2009.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Increased FGF-23 concentration in normophosphatemic dogs with CKD was associated with significant risk of development of hyperphosphatemia, independent of CKD stage, and of the progression of CKD. Future research focusing on whether interventions that decrease FGF-23 secretion will slow the development of hyperphosphatemia and CKD progression is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.16237","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T16:42:08Z","timestamp":1629564128000},"page":"2296-2305","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between serum fibroblast growth factor-23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3503-8370","authenticated-orcid":false,"given":"Hirosumi","family":"Miyakawa","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine II, Nippon Veterinary and Life Science University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai-Hsun","family":"Hsu","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine II, Nippon Veterinary and Life Science University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-8363","authenticated-orcid":false,"given":"Mizuki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine II, Nippon Veterinary and Life Science University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-241X","authenticated-orcid":false,"given":"Ryota","family":"Akabane","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine II, Nippon Veterinary and Life Science University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine II, Nippon Veterinary and Life Science University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Takemura","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine II, Nippon Veterinary and Life Science University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"2026020303474068200_jvim16237-bib-0001","first-page":"1938","article-title":"Text of Veterinary Internal Medicine","author":"Polzin","year":"2017","edition":"8th ed"},{"key":"2026020303474068200_jvim16237-bib-0002","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The chronic kidney disease - mineral bone disorder (CKD-MBD): advances in pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone"},{"key":"2026020303474068200_jvim16237-bib-0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/nep.13457","article-title":"Mineral bone disorders in chronic kidney disease","volume":"23","author":"Hou","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"2026020303474068200_jvim16237-bib-0004","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2026020303474068200_jvim16237-bib-0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.cvsm.2016.06.003","article-title":"Update on mineral and bone disorders in chronic kidney disease","volume":"46","author":"Foster","year":"2016","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303474068200_jvim16237-bib-0006","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V1101169","article-title":"Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass","volume":"1","author":"Brown","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"2026020303474068200_jvim16237-bib-0007","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2460\/ajvr.1992.53.01.157","article-title":"Effects of phosphorus\/calcium-restricted and phosphorus\/calcium-replete 32% protein diets in dogs with chronic renal failure","volume":"53","author":"Finco","year":"1992","journal-title":"Am J Vet Res"},{"key":"2026020303474068200_jvim16237-bib-0008","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.2460\/ajvr.1992.53.12.2264","article-title":"Effects of dietary phosphorus and protein in dogs with chronic renal failure","volume":"53","author":"Finco","year":"1992","journal-title":"Am J Vet Res"},{"key":"2026020303474068200_jvim16237-bib-0009","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/jvim.15322","article-title":"Factors associated with survival in dogs with chronic kidney disease","volume":"32","author":"Rudinsky","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234712","article-title":"Nutritional and laboratory parameters affect the survival of dogs with chronic kidney disease","volume":"15","author":"Pedrinelli","year":"2020","journal-title":"PLoS One"},{"key":"2026020303474068200_jvim16237-bib-0011","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ndt\/gfh827","article-title":"With or without the kidney: the role of FGF23 in CKD","volume":"20","author":"Fukagawa","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2026020303474068200_jvim16237-bib-0012","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1873-3468.13494","article-title":"Regulation of fibroblast growth factor 23 (FGF23) in health and disease","volume":"593","author":"B\u00e4r","year":"2019","journal-title":"FEBS Lett"},{"key":"2026020303474068200_jvim16237-bib-0013","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/gft065","article-title":"Fibroblast growth factor-23: what we know, what we don't know, and what we need to know","volume":"28","author":"Kovesdy","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2026020303474068200_jvim16237-bib-0014","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2026020303474068200_jvim16237-bib-0015","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","article-title":"Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism","volume":"5","author":"Evenepoel","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026020303474068200_jvim16237-bib-0016","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jvim.12044","article-title":"Fibroblast growth factor 23 in feline chronic kidney disease","volume":"27","author":"Geddes","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0017","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2026020303474068200_jvim16237-bib-0018","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/jvim.14707","article-title":"Fibroblast growth factor-23 concentration in dogs with chronic kidney disease","volume":"31","author":"Harjes","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0019","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jsap.13244","article-title":"Fibroblast growth factor-23 as an early marker of CKD-mineral bone disorder in dogs: preliminary investigation","volume":"61","author":"Miyakawa","year":"2020","journal-title":"J Small Anim Pract"},{"key":"2026020303474068200_jvim16237-bib-0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1152\/ajprenal.90538.2008","article-title":"FGF23-mediated regulation of systemic phosphate homeostasis: is klotho an essential player?","volume":"296","author":"Razzaque","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026020303474068200_jvim16237-bib-0021","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ki.2008.643","article-title":"Latest findings in phosphate homeostasis","volume":"75","author":"Pri\u00e9","year":"2009","journal-title":"Kidney Int"},{"key":"2026020303474068200_jvim16237-bib-0022","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/toxins11030175","article-title":"FGF23, biomarker or target?","volume":"11","author":"Rodelo-Haad","year":"2019","journal-title":"Toxins (Basel)"},{"key":"2026020303474068200_jvim16237-bib-0023","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2026020303474068200_jvim16237-bib-0024","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"2026020303474068200_jvim16237-bib-0025","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026020303474068200_jvim16237-bib-0026","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jvim.13625","article-title":"Relationship between plasma fibroblast growth factor-23 concentration and survival time in cats with chronic kidney disease","volume":"29","author":"Geddes","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0027","author":"International Renal Interest Society","year":"2019"},{"key":"2026020303474068200_jvim16237-bib-0028","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/jvim.15331","article-title":"ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"32","author":"Acierno","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0029","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2026020303474068200_jvim16237-bib-0030","author":"International Renal Interest Society","year":"2019"},{"key":"2026020303474068200_jvim16237-bib-0031","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cvsm.2016.10.012","article-title":"A quick reference on respiratory acidosis","volume":"47","author":"Johnson","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303474068200_jvim16237-bib-0032","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cvsm.2016.10.016","article-title":"A quick reference on hypercalcemia","volume":"47","author":"de Brito Galv\u00e3o","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303474068200_jvim16237-bib-0033","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2460\/javma.2005.226.393","article-title":"Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure","volume":"226","author":"Jacob","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303474068200_jvim16237-bib-0034","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2460\/javma.2003.222.322","article-title":"Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure","volume":"222","author":"Jacob","year":"2003","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303474068200_jvim16237-bib-0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.clinbiochem.2011.01.009","article-title":"Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease","volume":"44","author":"Filler","year":"2011","journal-title":"Clin Biochem"},{"key":"2026020303474068200_jvim16237-bib-0036","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026020303474068200_jvim16237-bib-0037","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/toxins8120369","article-title":"Fibroblast growth factor-23-a potential uremic toxin","volume":"8","author":"Kuczera","year":"2016","journal-title":"Toxins (Basel)"},{"key":"2026020303474068200_jvim16237-bib-0038","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the mild to moderate kidney disease (MMKD) study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026020303474068200_jvim16237-bib-0039","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2215\/CJN.02110216","article-title":"Fibroblast growth factor 23 and risk of CKD progression in children","volume":"11","author":"Portale","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026020303474068200_jvim16237-bib-0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/jvim.15457","article-title":"The association of indoxyl sulfate with fibroblast growth factor-23 in cats with chronic kidney disease","volume":"33","author":"Liao","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0041","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.61.3.319","article-title":"Renal damage following the ingestion of a diet containing an excess of inorganic phosphate","volume":"61","author":"Mackay","year":"1935","journal-title":"J Exp Med"},{"key":"2026020303474068200_jvim16237-bib-0042","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1980.85","article-title":"Renal toxicity of phosphate in rats","volume":"17","author":"Haut","year":"1980","journal-title":"Kidney Int"},{"key":"2026020303474068200_jvim16237-bib-0043","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/030098588001700607","article-title":"Potassium hydrogen phosphate induced nephropathy in the dog. I. Pathogenesis of tubular atrophy (author's transl)","volume":"17","author":"Schneider","year":"1980","journal-title":"Vet Pathol"},{"key":"2026020303474068200_jvim16237-bib-0044","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/vr.164.16.487","article-title":"Serum phosphorus concentrations in dogs with leishmaniosis at different stages of chronic kidney disease","volume":"164","author":"Cortadellas","year":"2009","journal-title":"Vet Rec"},{"key":"2026020303474068200_jvim16237-bib-0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1939-1676.2009.0415.x","article-title":"Calcium and phosphorus homeostasis in dogs with spontaneous chronic kidney disease at different stages of severity","volume":"24","author":"Cortadellas","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0046","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2460\/javma.245.10.1135","article-title":"Prognostic role of the product of serum calcium and phosphorus concentrations in dogs with chronic kidney disease: 31 cases (2008-2010)","volume":"245","author":"Lippi","year":"2014","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303474068200_jvim16237-bib-0047","first-page":"1319","article-title":"A plasma calcium-phosphorus product can be used to predict the lifespan of dogs with chronic kidney disease","volume":"60","author":"Lucero","year":"2019","journal-title":"Can Vet J"},{"key":"2026020303474068200_jvim16237-bib-0048","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2460\/javma.2002.220.1163","article-title":"Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs","volume":"220","author":"Jacob","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303474068200_jvim16237-bib-0049","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jvim.12246","article-title":"Evaluation of the effects of a therapeutic renal diet to control proteinuria in proteinuric non-azotemic dogs treated with benazepril","volume":"28","author":"Cortadellas","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4314\/ovj.v6i2.8","article-title":"The effect of renal diet in association with enalapril or benazepril on proteinuria in dogs with proteinuric chronic kidney disease","volume":"6","author":"Zatelli","year":"2016","journal-title":"Open Vet J"},{"key":"2026020303474068200_jvim16237-bib-0051","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jpn.12692","article-title":"A longitudinal study on the acceptance and effects of a therapeutic renal food in pet dogs with IRIS-stage 1 chronic kidney disease","volume":"102","author":"Hall","year":"2018","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"2026020303474068200_jvim16237-bib-0052","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/jvim.12230","article-title":"Consensus recommendations for standard therapy of glomerular disease in dogs","volume":"27","author":"IRIS Canine GN Study Group Standard Therapy Subgroup","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0053","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10157-014-0947-4","article-title":"Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease","volume":"18","author":"Goto","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"2026020303474068200_jvim16237-bib-0054","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/jvim.12187","article-title":"The effect of feeding a renal diet on plasma fibroblast growth factor 23 concentrations in cats with stable azotemic chronic kidney disease","volume":"27","author":"Geddes","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/vr.162.5.141","article-title":"Associations between proteinuria, systemic hypertension and glomerular filtration rate in dogs with renal and non-renal diseases","volume":"162","author":"Wehner","year":"2008","journal-title":"Vet Rec"},{"key":"2026020303474068200_jvim16237-bib-0056","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/jvim.15958","article-title":"Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: a double-masked, randomized clinical trial","volume":"34","author":"Louren\u00e7o","year":"2020","journal-title":"J Vet Intern Med"},{"key":"2026020303474068200_jvim16237-bib-0057","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/jvim.16102","article-title":"Effect of telmisartan, angiotensin-converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs","volume":"35","author":"Fowler","year":"2021","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.16237","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.16237","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/35\/5\/2296\/66673487\/jvim16237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/35\/5\/2296\/66673487\/jvim16237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:48:09Z","timestamp":1770108489000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/35\/5\/2296\/8449791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.16237","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"2021-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}